The role of the Boudouard and water-gas shift reactions in the methanation of CO or CO2 over Ni/γ-Al2O3 catalyst

The Boudouard and the water-gas shift reactions were studied at different temperatures between 453 and 490 K over a Ni/γ-Al2O3 catalyst in a Carberry batch reactor using various mixtures of CO, H2 and CO2. The activity of the Boudouard reaction was found to be low, compared to the water-gas shift reaction, and diminished over time, suggesting that the temperature was too low for significant activity after an initiation period of CO adsorption. Furthermore, the rate of the Boudouard reaction has been reported to decrease in the presence of H2O and H2. The water-gas shift reaction was found to be the main reaction responsible for the production of CO2 in a mixture of CO, H2 and H2O in the batch reactor. The ratio of the total amount of CO consumed to the total amount of CO2 produced showed that the catalyst was also active towards hydrogenation, where the rate of the hydrogenation reaction was very much faster than the water-gas shift reaction. The resulting ratio of pH2 to pCO was found to be extremely low, probably leading to the production of long-chain hydrocarbons. The stoichiometry of the overall reaction was such that for every mole of mole of CO2 produced, 1.5 mol of CO was consumed in the batch reactor. Kinetic studies were performed in the batch reactor. An Eley-Rideal mechanism was found to provide a good agreement with the experimental results over a wide range of partial pressures of steam and CO

Acute inhibition of MEK suppresses congenital melanocytic nevus syndrome in a murine model driven by activated NRAS and Wnt signaling

Congenital melanocytic nevus (CMN) syndrome is the association of pigmented melanocytic nevi with extra-cutaneous features, classically melanotic cells within the central nervous system, most frequently caused by a mutation of NRAS codon 61. This condition is currently untreatable and carries a significant risk of melanoma within the skin, brain, or leptomeninges. We have previously proposed a key role for Wnt signaling in the formation of melanocytic nevi, suggesting that activated Wnt signaling may be synergistic with activated NRAS in the pathogenesis of CMN syndrome. Some familial pre-disposition suggests a germ-line contribution to CMN syndrome, as does variability of neurological phenotypes in individuals with similar cutaneous phenotypes. Accordingly, we performed exome sequencing of germ-line DNA from patients with CMN to reveal rare or undescribed Wnt-signaling alterations. A murine model harboring activated NRASQ61K and Wnt signaling in melanocytes exhibited striking features of CMN syndrome, in particular neurological involvement. In the first model of treatment for this condition, these congenital, and previously assumed permanent, features were profoundly suppressed by acute post-natal treatment with a MEK inhibitor. These data suggest that activated NRAS and aberrant Wnt signaling conspire to drive CMN syndrome. Post-natal MEK inhibition is a potential candidate therapy for patients with this debilitating condition

Kinetic studies of CO2 methanation over a Ni/γ-Al2O3 catalyst using a batch reactor

The methanation of CO2 was investigated over a wide range of partial pressures of products and reactants using a gradientless, spinning-basket reactor operated in batch mode. The rate and selectivity of CO2 methanation, using a 12 wt% Ni/γ–Al2O3 catalyst, were explored at temperatures 453–483 K and pressures up to 20 bar. The rate was found to increase with increasing partial pressures of H2 and CO2 when the partial pressures of these reactants were low; however, the rate of reaction was found to be insensitive to changes in the partial pressures of H2 and CO2 when their partial pressures were high. A convenient method of determining the effect of H2O on the rate of reaction was also developed using the batch reactor and the inhibitory effect of H2O on CO2 methanation was quantified. The kinetic measurements were compared with a mathematical model of the reactor, in which different kinetic expressions were explored. The kinetics of the reaction were found to be consistent with a mechanism in which adsorbed CO2 dissociated to adsorbed CO and O on the surface of the catalyst with the rate-limiting step being the subsequent dissociation of adsorbed CO

Reading football in Brazil through a boy’s own story

This is an Accepted Manuscript of an article published in Qualitative Research in Sport, Exercise and Health on 12 Feb 2014, available online: http://www.tandfonline.com/10.1080/2159676X.2013.877962This essay is a contribution to debates about football in Brazil. It is also an attempt to engage in discussions about how we come to know and talk about the social world around us. The central element of the essay is the story of one young man’s interaction with a particular sporting space and the emotions and insights that are triggered by memories of that place, situated as it is in a rapidly developing country but retaining many of the problems associated with under development. Absolved from any responsibility to adhere to a dominant value system or to feel constrained by research ethics, the storyteller is free to offer honest, if conflicted, personal reflections on a range of issues, including poverty, ‘race’ and sporting values. The result is a story which does not negate the necessity of more orthodox research on sport in Brazil, particularly related to the hosting of sport mega events but which reminds us of the importance of understanding the world through everyday personal experience

History of clinical transplantation

How transplantation came to be a clinical discipline can be pieced together by perusing two volumes of reminiscences collected by Paul I. Terasaki in 1991-1992 from many of the persons who were directly involved. One volume was devoted to the discovery of the major histocompatibility complex (MHC), with particular reference to the human leukocyte antigens (HLAs) that are widely used today for tissue matching.1 The other focused on milestones in the development of clinical transplantation.2 All the contributions described in both volumes can be traced back in one way or other to the demonstration in the mid-1940s by Peter Brian Medawar that the rejection of allografts is an immunological phenomenon.3,4 © 2008 Springer New York

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings

Background:Antiretroviral regimens with simplified dosing and better safety are needed to maximize the efficiency of antiretroviral delivery in resource-limited settings. We investigated the efficacy and safety of antiretroviral regimens with once-daily compared to twice-daily dosing in diverse areas of the world.Methods and Findings:1,571 HIV-1-infected persons (47% women) from nine countries in four continents were assigned with equal probability to open-label antiretroviral therapy with efavirenz plus lamivudine-zidovudine (EFV+3TC-ZDV), atazanavir plus didanosine-EC plus emtricitabine (ATV+DDI+FTC), or efavirenz plus emtricitabine-tenofovir-disoproxil fumarate (DF) (EFV+FTC-TDF). ATV+DDI+FTC and EFV+FTC-TDF were hypothesized to be non-inferior to EFV+3TC-ZDV if the upper one-sided 95% confidence bound for the hazard ratio (HR) was ≤1.35 when 30% of participants had treatment failure.An independent monitoring board recommended stopping study follow-up prior to accumulation of 472 treatment failures. Comparing EFV+FTC-TDF to EFV+3TC-ZDV, during a median 184 wk of follow-up there were 95 treatment failures (18%) among 526 participants versus 98 failures among 519 participants (19%; HR 0.95, 95% CI 0.72-1.27; p = 0.74). Safety endpoints occurred in 243 (46%) participants assigned to EFV+FTC-TDF versus 313 (60%) assigned to EFV+3TC-ZDV (HR 0.64, CI 0.54-0.76; p<0.001) and there was a significant interaction between sex and regimen safety (HR 0.50, CI 0.39-0.64 for women; HR 0.79, CI 0.62-1.00 for men; p = 0.01). Comparing ATV+DDI+FTC to EFV+3TC-ZDV, during a median follow-up of 81 wk there were 108 failures (21%) among 526 participants assigned to ATV+DDI+FTC and 76 (15%) among 519 participants assigned to EFV+3TC-ZDV (HR 1.51, CI 1.12-2.04; p = 0.007).Conclusion: EFV+FTC-TDF had similar high efficacy compared to EFV+3TC-ZDV in this trial population, recruited in diverse multinational settings. Superior safety, especially in HIV-1-infected women, and once-daily dosing of EFV+FTC-TDF are advantageous for use of this regimen for initial treatment of HIV-1 infection in resource-limited countries. ATV+DDI+FTC had inferior efficacy and is not recommended as an initial antiretroviral regimen.Trial Registration:http://www.ClinicalTrials.gov NCT00084136

Patient knowledge and understanding of treatment options for localised prostate cancer facilitated and increased by the use of the video medium

Available from British Library Document Supply Centre-DSC:DX036474 / BLDSC - British Library Document Supply CentreSIGLEGBUnited Kingdo

Patient knowledge and understanding of treatment options for localised prostate cancer facilitated and increased by the use of the video medium

Available from British Library Document Supply Centre-DSC:DX036474 / BLDSC - British Library Document Supply CentreSIGLEGBUnited Kingdo